TeliosRx Consulting

“TeliosRx is an independent pharmacy benefit consulting firm. The name is derived from the Greek 'Telios' — perfection, completeness, maturity. We help self-insured employers, health plans, and benefit funds control pharmacy spend through PBM RFP management, contract negotiation, GLP-1 strategy, oversight, analytics, and specialty pharmacy guidance.”

Products & services

Questions & answers

What does TeliosRx do?

“TeliosRx is an independent pharmacy benefit consulting firm. We help self-insured employers, health plans, and benefit funds manage their PBM relationships through RFP management, contract negotiation, oversight, analytics, GLP-1 strategy, and specialty pharmacy guidance.”

How is TeliosRx different from a PBM?

“PBMs are vendors. TeliosRx is an independent consultant on the client's side of the table. We are 100% client-funded and accept zero compensation from PBMs, drug manufacturers, or distributors — so our analysis is free of the conflicts that compromise traditional broker-led pharmacy advice.”

Who are the founders of TeliosRx?

“TeliosRx Consulting, LLC was co-founded by Wende Ward (Managing Partner, 25+ years in pharmacy benefits leadership) and Dr. Kali Panagos, PharmD, RPh (Managing Partner, active clinical pharmacist specializing in formulary and specialty drug strategy).”

Data formats & record details

Download this profile and inspect its supporting evidence.

Entity ID
urn:readyscan:entity:teliosrx-consulting-q139845208
Material fingerprint
fnv1a64:6c80aedbf2cde56c
Entity revision
fnv1a64:bfef1d0c27d40691
Published
2026-10-24
Modified
2026-10-24
Source summary
TeliosRx Consulting, LLC: “TeliosRx is an independent pharmacy benefit consulting firm. The name is derived from the Greek 'Telios' — perfection, completeness, maturity. We help self-insured employers, health plans, and benefit funds control pharmacy spend through PBM RFP management, contract negotiation, GLP-1 strategy, oversight, analytics, and specialty pharmacy guidance.”
Evidence record
urn:readyscan:corpus:evidence:teliosrx-consulting-q139845208